Skip to main content

Table 2 Procedural data and results

From: Short- to mid-term outcomes after transcatheter aortic valve replacement in patients with ascending aorta dilation: a single-centre retrospective analysis

 

Non-AAD

(n = 166)

AAD

(n = 73)

p value

Emergency surgery

9 (5.4)

2 (2.7)

0.511

General anaesthesia

137 (82.5)

60 (82.2)

0.950

Access

   

 Transfemoral

160 (96.4)

69 (94.5)

0.755

 Non-transfemoral (Carotid, Subclavian)

6 (3.6)

4 (5.5)

Valve type

   

 Self-expandable valve (Venus-A, VitaFlow, TaurusOne)

147 (88.6)

65 (89.0)

0.767

 Balloon-expandable valve (Sapien3, Sapien XT)

19 (11.4)

8 (11.0)

 Balloon pre-dilation

149 (89.8)

63 (86.3)

0.437

 Balloon post-dilation

20 (12.0)

17 (23.3)

0.027

Post-procedure AR grade

   

≥ mild

64 (38.6)

29 (39.7)

0.864

 ≥ moderate

2 (1.2)

1 (1.4)

1.000

 Conversion to open surgery

6 (3.6)

1 (1.4)

0.679

 Second valve implantation

30 (18.1)

10 (13.7)

0.404

 Device migration to ventricle

20 (12.0)

4 (5.5)

 

 Paravalvular leakage

6 (3.6)

4 (5.5)

 

 Device expand inadequately

4 (2.4)

1 (1.4)

 

 Left ventricular ejection fraction at discharge, %

60.0 (55.0–65.0)

60.0 (50.0–65.0)

0.435

  1. Values are mean ± SD, n (%), or median (interquartile range). AAD ascending aorta dilation